Clinical Trial Update: Varenicline for Nicotine Vaping Cessation in Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated varenicline for nicotine vaping cessation in adolescents; the study has completed and results were posted in April 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vaping, Nicotine Dependence | Phase 4 | Status: COMPLETED | Results posted: 2025-04-27